Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
Condition: Influenza InfectionInterventions: Biological: GSK2340274A; Biological: GSK2340273ASponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified January 2012
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials